Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naim Alkhouri

Showing results (291-300 of 306) with videos related to

Pageof 31
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 8, 2025
Expert Delphi Consensus on Surrogate Endpoints for Treatment Assessment in Metabolic Dysfunction-associated SteatohepatitisArun J Sanyal, Atsushi Nakajima, Elisabetta Bugianesi, et al.
The American Journal of Gastroenterology|March 27, 2025
ALADDIN: A Machine Learning Approach to Enhance the Prediction of Significant Fibrosis or Higher in Metabolic Dysfunction-Associated Steatotic Liver DiseaseNaim Alkhouri, Terry Cheuk-Fung Yip, Laurent Castera, et al.
Hepatology (Baltimore, Md.)|November 10, 2020
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASHRohit Loomba, Mazen Noureddin, Kris V Kowdley, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 15, 2019
Clinical Practice Approach to Nonalcoholic Fatty Liver Disease by Pediatric Gastroenterologists in the United StatesWarren L Shapiro, Elizabeth L Yu, Jennifer C Arin, et al.
Nature Medicine|June 5, 2025
The People-First Liver CharterJeffrey V Lazarus, Dana Ivancovsky Wajcman, Silvana Pannain, et al.
Journal of Hepatology|June 23, 2023
A global research priority agenda to advance public health responses to fatty liver diseaseJeffrey V Lazarus, Henry E Mark, Alina M Allen, et al.
Hepatology (Baltimore, Md.)|August 4, 2023
A global action agenda for turning the tide on fatty liver diseaseJeffrey V Lazarus, Henry E Mark, Alina M Allen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2019
Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular CarcinomaNicole E Rich, Ju Dong Yang, Ponni V Perumalswami, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 26, 2025
Diagnostic Performance of LIVERFASt as a Non-invasive Liver Fibrosis Test: Data from Three Cohorts of Patients with Metabolic Dysfunction-associated Steatotic Liver DiseaseNaim Alkhouri, Parvez Mantry, Humberto C Gonzalez, et al.
Gastroenterology|April 13, 2025
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and SteatohepatitisZobair M Younossi, Shira Zelber-Sagi, Jeffrey V Lazarus, et al.
Pageof 31

Showing results (291-300 of 306) with videos related to

Sort By:
Pageof 31
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 8, 2025
Expert Delphi Consensus on Surrogate Endpoints for Treatment Assessment in Metabolic Dysfunction-associated SteatohepatitisArun J Sanyal, Atsushi Nakajima, Elisabetta Bugianesi, et al.
The American Journal of Gastroenterology|March 27, 2025
ALADDIN: A Machine Learning Approach to Enhance the Prediction of Significant Fibrosis or Higher in Metabolic Dysfunction-Associated Steatotic Liver DiseaseNaim Alkhouri, Terry Cheuk-Fung Yip, Laurent Castera, et al.
Hepatology (Baltimore, Md.)|November 10, 2020
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASHRohit Loomba, Mazen Noureddin, Kris V Kowdley, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 15, 2019
Clinical Practice Approach to Nonalcoholic Fatty Liver Disease by Pediatric Gastroenterologists in the United StatesWarren L Shapiro, Elizabeth L Yu, Jennifer C Arin, et al.
Nature Medicine|June 5, 2025
The People-First Liver CharterJeffrey V Lazarus, Dana Ivancovsky Wajcman, Silvana Pannain, et al.
Journal of Hepatology|June 23, 2023
A global research priority agenda to advance public health responses to fatty liver diseaseJeffrey V Lazarus, Henry E Mark, Alina M Allen, et al.
Hepatology (Baltimore, Md.)|August 4, 2023
A global action agenda for turning the tide on fatty liver diseaseJeffrey V Lazarus, Henry E Mark, Alina M Allen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2019
Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular CarcinomaNicole E Rich, Ju Dong Yang, Ponni V Perumalswami, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|December 26, 2025
Diagnostic Performance of LIVERFASt as a Non-invasive Liver Fibrosis Test: Data from Three Cohorts of Patients with Metabolic Dysfunction-associated Steatotic Liver DiseaseNaim Alkhouri, Parvez Mantry, Humberto C Gonzalez, et al.
Gastroenterology|April 13, 2025
Global Consensus Recommendations for Metabolic Dysfunction-Associated Steatotic Liver Disease and SteatohepatitisZobair M Younossi, Shira Zelber-Sagi, Jeffrey V Lazarus, et al.
Pageof 31